NCT05211895 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC Status RECRUITING Phase PHASE3
NCT05205161 A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE1
NCT05203458 Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients Status COMPLETED Phase N/A
NCT05202262 A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS) Status COMPLETED Phase PHASE3
NCT05197192 A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL Status RECRUITING Phase PHASE3
NCT05188144 Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom. Status COMPLETED Phase N/A
NCT05184998 Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels Status COMPLETED Phase N/A
NCT05184062 A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults Status COMPLETED Phase PHASE2
NCT05182905 AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05180357 RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps. Status COMPLETED Phase N/A
NCT05171816 Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05169619 Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal Status COMPLETED Phase N/A
NCT05167175 The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation Status UNKNOWN Phase PHASE2
NCT05166889 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations Status COMPLETED Phase PHASE3
NCT05166421 Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants Status COMPLETED Phase PHASE1
NCT05161533 Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial Status WITHDRAWN Phase PHASE2
NCT05160974 QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing Surveillance Status COMPLETED Phase N/A
NCT05158387 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations. Status COMPLETED Phase PHASE3